Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100045111Phase 4Recruiting
Phase 4, randomised trial in gallbladder disease comparing Propofol + remifentanil with Sevoflurane + remifentanil (2 arms). Primary endpoints: Anesthesia effect, Safety and 1 more. Started Jan 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100045111.